DÄ internationalArchive35-36/2019Central pontine myelinolysis and osmotic demyelination syndrome

Review article

Central pontine myelinolysis and osmotic demyelination syndrome

Dtsch Arztebl Int 2019; 116: 600-6. DOI: 10.3238/arztebl.2019.0600

Lambeck, J; Hieber, M; Dreßing, A; Niesen, W

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

*1Die beiden Autoren teilen sich die Erstautorenschaft.
*2Die beiden Autoren teilen sich die Letztautorenschaft.
Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg:
Dr. med. Johann Lambeck, Dr. med. Maren Hieber,
Dr. med. Andrea
Dreßing, Dr. med. Wolf-Dirk Niesen
1.Adams RD, Victor M, Mancall EL. Central pontine myelinolysis. Arch Neurol Psychiatry 1959; 81: 154–72 CrossRef
2.Bhoi KK, Pandit A, Guha G, et al.: Reversible parkinsonism in central pontine and extrapontine myelinolysis: a report of five cases from India and review of the literature. Neurol Asia 2007; 12: 101–9.
3.Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP: Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry 2011; 82: 326–31 CrossRef MEDLINE
4.de Souza A, Desai PK: More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res 2012; 34: 262–71 CrossRef MEDLINE
5.de Souza A: Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord 2013; 19: 709–16 CrossRef MEDLINE
6.Rao PB, Azim A, Singh N, Baronia AK, Kumar A, Poddar B: Osmotic demyelination syndrome in Intensive Care Unit. Indian J Crit Care Med 2015; 19: 166–9 CrossRef MEDLINE PubMed Central
7.Berlit P: Die zentrale pontine Myelinolyse. Nervenarzt 1986; 57: 624–33.
8.Singh TD, Fugate JE, Rabinstein AA: Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 2014, 21: 1443–50 CrossRef MEDLINE
9.Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002; 47: 3–10 CrossRef MEDLINE
10.Burcar PJ, Norenberg MD, Yarnell PR: Hyponatriemia and central pontine myelinolysis. Neurology 1977; 27: 223–6 CrossRef MEDLINE
11.Sugimoto T, Murata T, Omori M, Wada Y: Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa. J Neurol Neurosurg Psychiatry 2003; 74: 353–5 CrossRef MEDLINE PubMed Central
12.Morard I, Gasche Y, Kneteman M et al.: Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: A case–control study. Neurocrit Care 2014; 20: 287–95 CrossRef MEDLINE
13.Alleman AM: Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR 2014; 35: 153–9 CrossRef MEDLINE
14.Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF: Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun 2013; 1: 40 CrossRef MEDLINE PubMed Central
15.Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75: iii22–8 CrossRef MEDLINE PubMed Central
16.Kleinschmidt-DeMasters BK, Rojiani AM, Filley CM: Central and extrapontine myelinolysis: Then and now. J Neuropathol Exp Neurol. 2006; 65: 1–11 CrossRefMEDLINE
17.Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD: Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res 2002; 33: 237–44 CrossRef
18.Sterns RH, Silver SM: Brain volume regulation in response to hypo-osmolality and its correction. Am J Med 2006; 119: S12–6 CrossRef MEDLINE
19.Seiser A, Schwarz S, Aichinger-Steiner MM, Funk G, Schnider P, Brainin M: Parkinsonism and dystonia in central pontine and extrapontine myelinolysis. J Neurol Neurosurg Psychiatry. 1998; 65: 119–21 CrossRef MEDLINE PubMed Central
20.Garzon T, Mellibovsky L, Roquer J, Perich X, Diez-Perez A: Ataxic form of central pontine myelinolysis. Lancet Neurol 2002; 1: 517–8 CrossRef
21.Roh JH, Kim JH, Oh K, Kim SG, Park KW, Kim BJ: Cortical laminar necrosis caused by rapidly corrected hyponatremia. J Neuroimaging 2009; 19: 185–7 CrossRef MEDLINE
22.Odier C, Nguyen DK, Panisset M: Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol 2010; 257: 1176–80 CrossRef MEDLINE
23.Menger H, Jörg, J: Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 1999; 246: 700–5 CrossRef
24.Graff-Radford J, Fugate JE, Kaufmann TJ, Mandrekar JN, Rabinstein AA: Clinical and radiologic correlations of central pontine myelinolysis syndrome. Mayo Clin Proc 2011; 86: 1063–7 CrossRef MEDLINE PubMed Central
25.Miller GM, Baker HL, Okazaki H, Whisnant JP: Central pontine myelinolysis and its imitators: MR findings. Radiology 1988; 168: 795–802 CrossRef MEDLINE
26.Ruzek, KA, Campeau NG, Miller GM: Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol 2004; 25: 210–3.
27.Förster A, Nölte I, Wenz,H, Al-Zghloul M, Kerl HU, Brockmann C. et al.: Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology 2013; 55: 49–56 CrossRef MEDLINE
28.Chua GC, Sitoh YY, Lim CC, Chua HC, Ng PY: MRI Findings in Osmotic Myelinolysis. Clin Radiol 2002; 57: 800–6 CrossRef
29.Roh JK, Nam H, Lee MC: A case of central pontine and extrapontine myelinolysis with early hypermetabolism on 18FDG-PET scan. J Korean Med Sci 1998; 13: 99–102 CrossRef MEDLINE PubMed Central
30.Wu YC, Peng GS, Cheng CA, Lin CC, Huang WS, Hsueh CJ, Lee JT: (99m)Tc-TRODAT-1 and (123)I-IBZM SPECT studies in a patient with extrapontine myelinolysis with parkinsonian features. Ann Nucl Med 2009; 23: 409–12 CrossRef MEDLINE
31.Sterns RH, Cappuccio JD, Silver SM, Cohen EP: Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994; 4: 1522–30.
32.Sterns RH, Hix JK, Silver SM: Management of hyponatremia in the ICU. Chest 2013; 144: 672–9 CrossRef MEDLINE
33.Lohr JW: Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med 1994; 96: 408–13 CrossRef
34.Berl T, Quittnat-Pelletier F, Verbalis JG et al.: Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010; 21: 705–12 CrossRef MEDLINE PubMed Central
35.Spasovski G, Vanholder R, Allolio B et al.: Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014; 29: i1–39 CrossRef MEDLINE
36.Sugimura Y, Murase T, Takefuji S et al.: Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 2005; 192: 178–83 CrossRef MEDLINE
37.Kumon S, Usui R, Kuzuhara S, Nitta K, Koike M: The improvement of the outcome of osmotic demyelination syndrome by plasma exchange. Intern Med 2017; 56: 733–6 CrossRef MEDLINE PubMed Central
38.Murthy SB, Izadyar S, Dhamne M, Kass JS, Goldsmith CE: Osmotic demyelination syndrome: variable clinical and radiologic response to intravenous immunoglobulin therapy. Neurol Sci 2013; 34: 581–4 CrossRef MEDLINE
39.Takagi H, Sugimura Y, Suzuki H et al.: Minocycline prevents osmotic demyelination associated with aquaresis. Kidney Int 2014; 86: 954–64 CrossRef MEDLINE
40.Oya S, Tsutsumi K, Ueki K, Kirino T: Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 2001; 57: 1931–2 CrossRef MEDLINE